1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A high mutation load of m.14597A>G in MT-ND6 causes Leigh syndrome

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Leigh syndrome (LS) is an early-onset progressive neurodegenerative disorder associated with mitochondrial deficiency. m.14597A>G (p.Ile26Thr) in the MT-ND6 gene was reported to cause Leberʼs hereditary optic neuropathy (LHON) or dementia/dysarthria. In previous reports, less than 90% heteroplasmy was shown to result in adult-onset disease. Here, by whole mitochondrial sequencing, we identified m.14597A>G mutation of a patient with LS. PCR–RFLP analysis on fibroblasts from the patient revealed a high mutation load (> 90% heteroplasmy). We performed functional assays using cybrid cell models generated by fusing mtDNA-less rho0 HeLa cells with enucleated cells from patient fibroblasts carrying the m.14597A>G variant. Cybrid cell lines bearing the m.14597A>G variant exhibited severe effects on mitochondrial complex I activity. Additionally, impairment of cell proliferation, decreased ATP production and reduced oxygen consumption rate were observed in the cybrid cell lines bearing the m.14597A>G variant when the cells were metabolically stressed in medium containing galactose, indicating mitochondrial respiratory chain defects. These results suggest that a high mutation load of m.14597A>G leads to LS via a mitochondrial complex I defect, rather than LHON or dementia/dysarthria.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: found

          Leigh syndrome: One disorder, more than 75 monogenic causes.

          Leigh syndrome is the most common pediatric presentation of mitochondrial disease. This neurodegenerative disorder is genetically heterogeneous, and to date pathogenic mutations in >75 genes have been identified, encoded by 2 genomes (mitochondrial and nuclear). More than one-third of these disease genes have been characterized in the past 5 years alone, reflecting the significant advances made in understanding its etiological basis. We review the diverse biochemical and genetic etiology of Leigh syndrome and associated clinical, neuroradiological, and metabolic features that can provide clues for diagnosis. We discuss the emergence of genotype-phenotype correlations, insights gleaned into the molecular basis of disease, and available therapeutic options.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            MITOMAP: a human mitochondrial genome database—2004 update

            MITOMAP (http://www.MITOMAP.org), a database for the human mitochondrial genome, has grown rapidly in data content over the past several years as interest in the role of mitochondrial DNA (mtDNA) variation in human origins, forensics, degenerative diseases, cancer and aging has increased dramatically. To accommodate this information explosion, MITOMAP has implemented a new relational database and an improved search engine, and all programs have been rewritten. System administrative changes have been made to improve security and efficiency, and to make MITOMAP compatible with a new automatic mtDNA sequence analyzer known as Mitomaster.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              A Comprehensive Genomic Analysis Reveals the Genetic Landscape of Mitochondrial Respiratory Chain Complex Deficiencies

              Mitochondrial disorders have the highest incidence among congenital metabolic disorders characterized by biochemical respiratory chain complex deficiencies. It occurs at a rate of 1 in 5,000 births, and has phenotypic and genetic heterogeneity. Mutations in about 1,500 nuclear encoded mitochondrial proteins may cause mitochondrial dysfunction of energy production and mitochondrial disorders. More than 250 genes that cause mitochondrial disorders have been reported to date. However exact genetic diagnosis for patients still remained largely unknown. To reveal this heterogeneity, we performed comprehensive genomic analyses for 142 patients with childhood-onset mitochondrial respiratory chain complex deficiencies. The approach includes whole mtDNA and exome analyses using high-throughput sequencing, and chromosomal aberration analyses using high-density oligonucleotide arrays. We identified 37 novel mutations in known mitochondrial disease genes and 3 mitochondria-related genes (MRPS23, QRSL1, and PNPLA4) as novel causative genes. We also identified 2 genes known to cause monogenic diseases (MECP2 and TNNI3) and 3 chromosomal aberrations (6q24.3-q25.1, 17p12, and 22q11.21) as causes in this cohort. Our approaches enhance the ability to identify pathogenic gene mutations in patients with biochemically defined mitochondrial respiratory chain complex deficiencies in clinical settings. They also underscore clinical and genetic heterogeneity and will improve patient care of this complex disorder.
                Bookmark

                Author and article information

                Contributors
                ya-okazaki@juntendo.ac.jp
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                27 May 2021
                27 May 2021
                2021
                : 11
                : 11123
                Affiliations
                [1 ]GRID grid.258269.2, ISNI 0000 0004 1762 2738, Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, , Juntendo University, Graduate School of Medicine, ; Tokyo, Japan
                [2 ]GRID grid.258622.9, ISNI 0000 0004 1936 9967, Department of Life Science, Faculty of Science and Engineering, , Kindai University, ; Osaka, Japan
                [3 ]GRID grid.20515.33, ISNI 0000 0001 2369 4728, Faculty of Life and Environmental Sciences, , University of Tsukuba, ; Tsukuba, Japan
                [4 ]GRID grid.20515.33, ISNI 0000 0001 2369 4728, Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA Center), , University of Tsukuba, ; Ibaraki, Japan
                [5 ]GRID grid.411321.4, ISNI 0000 0004 0632 2959, Center for Medical Genetics and Department of Metabolism, , Chiba Children’s Hospital, ; Chiba, Japan
                [6 ]GRID grid.410802.f, ISNI 0000 0001 2216 2631, Department of Pediatrics and Clinical Genomics, Faculty of Medicine, , Saitama Medical University, ; Saitama, Japan
                [7 ]GRID grid.430047.4, ISNI 0000 0004 0640 5017, Center for Intractable Diseases, , Saitama Medical University Hospital, ; Saitama, Japan
                Article
                90196
                10.1038/s41598-021-90196-5
                8160132
                34045482
                212fff00-39a9-4c01-8aad-3c4f02e57309
                © The Author(s) 2021

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 20 February 2021
                : 6 May 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001691, Japan Society for the Promotion of Science;
                Award ID: JP16K09973
                Award ID: JP19H03624
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100009619, Japan Agency for Medical Research and Development;
                Award ID: JP18ek0109177
                Award ID: JP19ek0109273
                Award ID: JP20ek0109468
                Categories
                Article
                Custom metadata
                © The Author(s) 2021

                Uncategorized
                mutation,clinical genetics,neurological disorders
                Uncategorized
                mutation, clinical genetics, neurological disorders

                Comments

                Comment on this article